X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (62231) 62231
Book Review (3963) 3963
Publication (3518) 3518
Newspaper Article (2727) 2727
Book Chapter (254) 254
Conference Proceeding (139) 139
Dissertation (88) 88
Book / eBook (18) 18
Trade Publication Article (16) 16
Magazine Article (13) 13
Paper (12) 12
Newsletter (10) 10
Web Resource (8) 8
Data Set (5) 5
Government Document (3) 3
Journal / eJournal (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cytotoxicity (50733) 50733
index medicus (45733) 45733
humans (29412) 29412
animals (21551) 21551
apoptosis (15746) 15746
cancer (14252) 14252
mice (12946) 12946
toxicity (10392) 10392
cell line, tumor (9829) 9829
oncology (9445) 9445
proteins (8557) 8557
female (7783) 7783
immunology (7564) 7564
analysis (7561) 7561
pharmacology & pharmacy (6657) 6657
inhibition (6631) 6631
in-vitro (6601) 6601
biochemistry & molecular biology (6589) 6589
tumors (6327) 6327
male (6275) 6275
cell survival - drug effects (6272) 6272
research (5852) 5852
cells (5678) 5678
medicine (5631) 5631
chemotherapy (5529) 5529
cancer therapies (5454) 5454
research article (5354) 5354
expression (5309) 5309
cytotoxicity, immunologic (5287) 5287
antineoplastic agents - pharmacology (5286) 5286
apoptosis - drug effects (5245) 5245
cell line (5182) 5182
chemistry, medicinal (5015) 5015
health aspects (4922) 4922
oxidative stress (4854) 4854
multidisciplinary sciences (4826) 4826
gene expression (4787) 4787
toxicology (4783) 4783
kinases (4694) 4694
nanoparticles (4606) 4606
cell biology (4512) 4512
activation (4421) 4421
studies (4397) 4397
cell proliferation - drug effects (4305) 4305
lymphocytes (4299) 4299
cell cycle (4187) 4187
care and treatment (4171) 4171
cells, cultured (4123) 4123
science (4072) 4072
rats (4025) 4025
flow cytometry (3949) 3949
dose-response relationship, drug (3890) 3890
killer cells, natural - immunology (3700) 3700
deoxyribonucleic acid--dna (3553) 3553
cell death (3464) 3464
breast cancer (3428) 3428
drugs (3406) 3406
immunotherapy (3398) 3398
biology (3286) 3286
biocompatibility (3213) 3213
antioxidants (3147) 3147
article (3129) 3129
cell lines (3010) 3010
signal transduction (3010) 3010
rodents (3001) 3001
cytokines (2996) 2996
biotechnology (2953) 2953
inflammation (2927) 2927
medicine, research & experimental (2926) 2926
ligands (2858) 2858
derivatives (2813) 2813
antigens (2800) 2800
growth (2780) 2780
physiological aspects (2752) 2752
enzymes (2717) 2717
chemistry, multidisciplinary (2670) 2670
medical research (2645) 2645
cell proliferation (2642) 2642
antineoplastic agents - chemistry (2640) 2640
dna (2635) 2635
metastasis (2621) 2621
tumor cells, cultured (2573) 2573
cell growth (2532) 2532
leukemia (2472) 2472
mice, inbred balb c (2439) 2439
therapy (2439) 2439
anticancer properties (2430) 2430
chemistry (2428) 2428
cell culture (2414) 2414
in-vivo (2391) 2391
lymphocytes t (2385) 2385
structure-activity relationship (2376) 2376
phosphorylation (2375) 2375
mice, inbred c57bl (2368) 2368
biochemistry (2346) 2346
mitochondria (2266) 2266
drug resistance (2247) 2247
molecular structure (2208) 2208
biotechnology & applied microbiology (2194) 2194
genetic aspects (2185) 2185
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (64770) 64770
Japanese (107) 107
German (87) 87
Russian (81) 81
Chinese (70) 70
Korean (65) 65
French (47) 47
Spanish (27) 27
Portuguese (24) 24
Turkish (8) 8
Polish (7) 7
Italian (6) 6
Czech (5) 5
Serbian (5) 5
Croatian (3) 3
Indonesian (3) 3
Persian (3) 3
Arabic (2) 2
Hungarian (2) 2
Slovak (2) 2
Ukrainian (2) 2
Afrikaans (1) 1
Catalan (1) 1
Hebrew (1) 1
Malay (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 08/2017, Volume 548, Issue 7668, pp. 471 - 475
Cyclin-dependent kinases 4 and 6 (CDK4/6) are fundamental drivers of the cell cycle and are required for the initiation and progression of various... 
BREAST-CANCER | CELLS | METHYLATION | MULTIDISCIPLINARY SCIENCES | SENESCENCE | EXPRESSION | REQUIREMENT | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Viruses - genetics | Breast Neoplasms - immunology | Humans | Transcriptome | T-Lymphocytes, Regulatory - immunology | T-Lymphocytes, Regulatory - cytology | Female | Biological Mimicry - drug effects | Phosphorylation - drug effects | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Disease Models, Animal | Viruses - drug effects | Viruses - immunology | Antigen Presentation - immunology | Breast Neoplasms - drug therapy | T-Lymphocytes, Regulatory - drug effects | Animals | Breast Neoplasms - genetics | Repressor Proteins - biosynthesis | Signal Transduction - drug effects | Breast Neoplasms - pathology | Cell Cycle Checkpoints - drug effects | Protein Kinase Inhibitors - therapeutic use | RNA, Double-Stranded - genetics | Cell Line, Tumor | Interferons - metabolism | Antigen Presentation - drug effects | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Oncology, Experimental | Cancer cells | Physiological aspects | Research | Protein kinases | Immunity | Cyclins | Cancer | Cell proliferation | Flow cytometry | Animal models | Phosphorylation | Senescence | Peptides | Genomics | Immune clearance | Cytotoxicity | Lymphocytes T | Genomes | Kinases | Cancer therapies | Cyclin-dependent kinase 4 | E2F protein | Breast carcinoma | Cell growth | Lymphocytes | New combinations | Cell cycle | Inhibition | Deoxyribonucleic acid--DNA | Antigen presentation | Medical research | Immune response | Immunoregulation | Intracellular levels | Double-stranded RNA | Breast cancer | Pharmacology | Gene expression | Ribonucleic acid--RNA | Immune systems | Inhibitors | Immune checkpoint | Immunogenicity | Breast | DNA methyltransferase | Interferon | Retinoblastoma | Tumors | Apoptosis | Index Medicus
Journal Article
Small, ISSN 1613-6810, 03/2016, Volume 12, Issue 12, pp. 1615 - 1626
Journal Article
Cancer Letters, ISSN 0304-3835, 2016, Volume 375, Issue 2, pp. 313 - 322
Journal Article
Science, ISSN 0036-8075, 03/2018, Volume 359, Issue 6383, pp. 1537 - 1542
Journal Article
Journal of Agricultural and Food Chemistry, ISSN 0021-8561, 06/2018, Volume 66, Issue 23, pp. 5812 - 5820
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2013, Volume 8, Issue 8, pp. e71115 - e71115
Renal cell carcinoma (RCC) is the sixth most common cancer in the US. While RCC is highly metastatic, there are few therapeutics options available for patients... 
ACTIVATED-RECEPTOR-ALPHA | THERAPY | METABOLISM | MECHANISM | MULTIDISCIPLINARY SCIENCES | C-MYC | IDENTIFICATION | PEROXISOME PROLIFERATORS | CARCINOMA | EPIDEMIOLOGY | PROGRESSION | Immunohistochemistry | Tyrosine - pharmacology | Cyclin D1 - metabolism | Kidney Neoplasms - genetics | Apoptosis - drug effects | Humans | Carcinoma, Renal Cell - genetics | Cell Survival - genetics | Apoptosis - genetics | Immunoblotting | Kidney Neoplasms - metabolism | G1 Phase - drug effects | Glycolysis - drug effects | Tyrosine - analogs & derivatives | Glycolysis - genetics | Glycolysis - physiology | RNA Interference | Deoxyglucose - pharmacology | Cell Cycle Checkpoints - genetics | G1 Phase - genetics | Cell Survival - physiology | Cell Line | Cell Survival - drug effects | PPAR alpha - antagonists & inhibitors | Carcinoma, Renal Cell - pathology | Cell Cycle Checkpoints - physiology | PPAR alpha - genetics | Glucose - pharmacology | Cyclin-Dependent Kinase 4 - metabolism | G1 Phase - physiology | Proto-Oncogene Proteins c-myc - metabolism | Carcinoma, Renal Cell - metabolism | Resting Phase, Cell Cycle - genetics | Cell Cycle Checkpoints - drug effects | Resting Phase, Cell Cycle - physiology | Cell Line, Tumor | Glucose - metabolism | Kidney Neoplasms - pathology | Resting Phase, Cell Cycle - drug effects | Oxazoles - pharmacology | Apoptosis - physiology | PPAR alpha - metabolism | Metabolomics | Energy metabolism | Nephrology | Syngeneic grafts | Toxicity | c-Myc protein | Cytotoxicity | Myc protein | Cyclin D1 | Cancer therapies | Cyclin-dependent kinase 4 | Metastases | Proteins | Allografts | Cell cycle | Xenografts | Oxidation | Inhibition | Internal medicine | siRNA | Metabolism | Patients | Fatty acids | Pathology | MicroRNAs | Kidney cancer | Cell lines | Proteomics | Glycolysis | VHL protein | Regulatory proteins | Clear cell-type renal cell carcinoma | Cancer | Apoptosis | Kidney transplantation | Index Medicus
Journal Article
ChemMedChem, ISSN 1860-7179, 12/2018, Volume 13, Issue 24, pp. 2664 - 2676
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 5/2005, Volume 102, Issue 22, pp. 7958 - 7963
Journal Article
Nature, ISSN 0028-0836, 11/2017, Volume 551, Issue 7679, pp. 247 - 250
Acquired drug resistance prevents cancer therapies from achieving stable and complete responses(1). Emerging evidence implicates a key role for non-mutational... 
RESISTANCE | STATE | DEATH | MULTIDISCIPLINARY SCIENCES | FERROPTOSIS | Physiological aspects | Peroxidase | Drug resistance | Cancer cells | Cell survival | Mesenchyme | Genes | Melanoma | Lipid peroxidation | Cytotoxicity | Lipids | Kinases | Cancer therapies | Survival | Antioxidants | Cell death | Hydroperoxidase | Tumors | Cancer | Apoptosis | Index Medicus
Journal Article
Journal of Pharmacy and Pharmacology, ISSN 0022-3573, 09/2017, Volume 69, Issue 9, pp. 1155 - 1165
Journal Article